Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002584
UniProt IDQ8IVG5
Primary gene name(s)SAMD9L
Synonym gene name(s)C7orf6, DRIF2, KIAA2005, UEF
Protein nameSterile alpha motif domain-containing protein 9-like
Protein functionunknown
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q8IVG5
Gene Ontology
(Biological Process)
Complete annatation
endosomal vesicle fusion [GO:0034058]
Gene Ontology
(Molecular Function)
Complete annatation
unknown
Gene Ontology
(Cellular Component)
Complete annatation
unknown
Protein-protein interaction128519
Phylogenetic treeQ8IVG5
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      Postively associated
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: 8.907644611; Folds changes 16h: 4.137218061; Tested: untested;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.5976518901964140.1679649953494140.266480995333317
AZA vs. DISU0.08206873245667110.8097666267784620.983606394809128
AZA vs. IL70.3038227844695630.1142246281607220.866922366700179
AZA vs. SAHA0.2388227745532340.3275385306030970.699237474905975
DISU vs. CD30.6660933043117220.2441280897178340.370443610268435
DISU vs. IL70.21267613224110.5448700778064290.851296370803642
DISU vs. SAHA0.1582679848100940.6456284493765010.890442664435442
DMSO vs. AZA0.01115261243339640.946949271455731
DMSO vs. CD30.5987028002311610.1710237037958420.263847629051137
DMSO vs. DISU-0.07234175557147110.8302437474893680.981063856043689
DMSO vs. IL70.2996243134245860.09586861116671320.5671975327073
DMSO vs. SAHA0.2205829930430550.3494001764242640.699868428879596
HIV vs. Mock in Activation0.5656227343286230.5197025481673030.999983755607037
HIV vs. Mock in Latency0.1173513567948830.4759947395983780.999834320637052
IL7 vs. CD30.9087332143825460.04159193806332250.0943385044272235
SAHA vs. CD30.8119414760885670.06435609057985560.12210075349848
SAHA vs. IL7-0.06822577912711420.7791347112898590.902742247346912
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change Inf
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
2.4 9.60E-05 1.6 0.000815666 2.1 0.01601002
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 1.36511 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
0.132 0.006

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.974 1.259 1.312 1.446 1.253
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found
Menu